Search

Few direct matches — filled in with the latest updates.

Tag: #ai-drug-dev1 results

Lemang Bio Raises 200M RMB for AI CAR-T

Lemang Bio Raises 200M RMB for AI CAR-T

Lemang Bio secured nearly 200M RMB in funding led by Yuecai Zhongyin and XtalPi to advance low-dose metabolic enhanced CAR-T clinical trials and production. The META 10 and META 10-AI platforms enable T-cell metabolic reprogramming for superior efficacy at ultra-low doses. Key progress includes CD19 CAR-T IND filing and IIT results showing 100% CR in B-ALL.